IRIDEXIRIX +2.18%61 14-Day RSI is 56.95 as of Jul. 02, 2026. GuruFocus rates IRIX with a GF Score™ of 61/100 and a GF Value™ of $1.70 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 870 Medical Devices & Instruments companies, IRIDEX ranks worse than 78.85% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-02), IRIDEX's 14-Day RSI is 56.95.
The industry rank for IRIDEX's 14-Day RSI or its related term are showing as below:
IRIX's 14-Day RSI is ranked worse than 78.85% of 870
companies
in the Medical Devices & Instruments industry
Industry Median: 46.975
vs IRIX: 56.95
IRIDEX (NAS:IRIX) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
IRIDEX 14-Day RSI Related Terms
IRIX vs ICCM, LFWD, GTHP: 14-Day RSI Comparison
For the Medical Devices subindustry, IRIDEX's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IRIDEX 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IRIDEX's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where IRIDEX's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IRIDEX (IRIX) has a 14-Day RSI of 56.95 as of Jul. 02, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on IRIDEX and its competitors. According to the industry distribution chart, IRIDEX ranks #686 out of 870 companies in the Medical Devices & Instruments industry, placing it in the top 78.9%.
Is IRIDEX's 14-Day RSI too high?
IRIDEX's current 14-Day RSI is 56.95. The Medical Devices & Instruments industry median 14-Day RSI is 46.98. IRIDEX's value of 56.95 is 21.2% above this industry median. Based on the distribution chart, IRIDEX ranks #686 out of 870 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, IRIDEX has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does IRIDEX's 14-Day RSI compare to ICCM and LFWD?
According to the Medical Devices & Instruments industry distribution chart, IRIDEX ranks #686 out of 870 companies for 14-Day RSI. This places IRIDEX in the lower half of its industry. The industry median 14-Day RSI is 46.98. IRIDEX's value of 56.95 is 21.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 46.98, based on 870 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IRIDEX's current 14-Day RSI of 56.95 is 21.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on IRIDEX and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 46.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IRIDEX's current 14-Day RSI is 56.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IRIDEX stock overvalued right now?
Based on GuruFocus' analysis, IRIDEX (IRIX) is currently considered Possible Value Trap. The stock's GF Value™ is $1.70, compared to a current price of $1.17 — trading 31.2% below its estimated fair value. The current 14-Day RSI is 56.95 and 21.2% above the Medical Devices & Instruments industry median of 46.98. IRIDEX's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For IRIDEX (IRIX), the current 14-Day RSI is 56.95 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IRIDEX (IRIX) Overvalued in 2026?
Based on GuruFocus' analysis, IRIDEX stock appears to be undervalued.
The current stock price of $1.17 is trading 31.2% below its estimated GF Value™ of $1.70.
GuruFocus considers IRIDEX to be Possible Value Trap.
Key valuation signals for IRIX:
14-Day RSI: 56.95
GF Value™: $1.70 vs. price of $1.17 (31.2% below fair value)
Industry Position: 21.2% above the Medical Devices & Instruments median (#686 of 870)
No single metric tells the full story. See the IRIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.
61GF Score
Get the complete analysis for IRIX
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IRIX has been successfully added to your 